FDAnews
www.fdanews.com/articles/145279-drug-for-rare-disease-may-lift-avi-biopharma-shares-barron-rsquo-s

Drug for Rare Disease May Lift AVI BioPharma Shares: Barron’s

April 2, 2012
AVI BioPharma’s shares could get a boost if its drug targeting treatment for a rare fatal form of muscular dystrophy proves to be effective in clinical drug trials, according to an article in the April 2 edition of Barron’s.
Reuters